LGALS3 and asthma: Evaluation of Galectin-3 expression in deficient and wild-type gal-3 mice with OVA-induced asthma, evidenced that OVA-sensitized gal-3 (−/−) mice developed fewer eosinophils, lower goblet cell metaplasia and significantly less AHR after airway OVA challenge compared to similarly treated gal-3 (+/+) mice [135].